Status:
UNKNOWN
Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
COVID, Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Context: Based on currently available data, most of national health authorities and consensus expert groups have written guidelines for the management of cancer patients in the context of COVID. Howe...
Eligibility Criteria
Inclusion
- EXPOSED PATIENTS:
- Age \> 18 years old
- Patients with a confirmed diagnosis of solid or hematologic cancer
- Patients who received their last anticancer treatment (surgery, systemic treatments or other localized treatment) in the past 5 years before SARS-CoV-2 infection
- Positive laboratory test (RT-PCR) proving the SARS-CoV-2 infection
- Patients hospitalized in one of the participating centers because of the SARS-CoV-2 infection
- Patients who are not opposed in participating to the ONCOVID-AURA study
- CONTROL PATIENTS:
- Age \> 18 years old
- Patients who have no cancer (neither solid nor hematologic tumors) or patients who received their last anticancer treatments more than five years before the SARS-CoV-2 infection
- Positive laboratory test (RT-PCR) proving the SARS-CoV-2 infection
- Patients hospitalized in one of the participating centers because of the SARS-CoV-2 infection
- Patients who are not opposed in participating to the ONCOVID-AURA study
Exclusion
- none
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2021
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04457570
Start Date
June 15 2020
End Date
February 15 2021
Last Update
July 7 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de lutte contre le Cancer JEAN PERRIN
Clermont-Ferrand, France
2
Centre Hospitalier Uniersitaire de Clermont-Ferrand
Clermont-Ferrand, France
3
Centre Leon Berard
Lyon, France
4
Centre Hospitalier Universitaire de St Etienne
Saint-Etienne, France